Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial ; volume:24 ; number:1 ; day:17 ; month:2 ; year:2020 ; pages:1-14 ; date:12.2020
Critical care ; 24, Heft 1 (17.2.2020), 1-14, 12.2020
- Urheber
-
Benítez-Cano, Adela
Luque, Sonia
Sorlí, Luisa
Carazo, Jesús
Ramos, Isabel
Campillo, Nuria
Curull, Víctor
Sánchez-Font, Albert
Vilaplana, Carles
Horcajada, Juan P.
Adalia, Ramón
Bermejo, Silvia
Samsó, Enric
Hope, William
Grau, Santiago
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-020-2763-4
- URN
-
urn:nbn:de:101:1-2020051404072547181675
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Benítez-Cano, Adela
- Luque, Sonia
- Sorlí, Luisa
- Carazo, Jesús
- Ramos, Isabel
- Campillo, Nuria
- Curull, Víctor
- Sánchez-Font, Albert
- Vilaplana, Carles
- Horcajada, Juan P.
- Adalia, Ramón
- Bermejo, Silvia
- Samsó, Enric
- Hope, William
- Grau, Santiago
- SpringerLink (Online service)
Ähnliche Objekte (12)
Meropenem: continuous or extended infusion?
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers
Meropenem: continuous or extended infusion?
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers
Meropenem: continuous or extended infusion?
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide